Nat Rev Drug Discov. 2006 Sep;5(9):723-9. Epub 2006 Aug 18.

Can open-source R&D reinvigorate drug research?

Source

Bernard Munos is at Eli Lilly & Co., Lilly Corporate Center, 1085, Indianapolis, Indiana 46285, USA. bhmunos@stanfordalumni.org

Abstract

The low number of novel therapeutics approved by the US FDA in recent years continues to cause great concern about productivity and declining innovation. Can open-source drug research and development, using principles pioneered by the highly successful open-source software movement, help revive the industry?

PMID:: 16915233; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Education

New England Research Institutes Inc.

Supplemental Content

Save items

Related citations in PubMed

Review Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressures. [Pharmacoeconomics. 2004]
Review Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressures.
Grabowski H. Pharmacoeconomics. 2004; 22(2 Suppl 2):15-24.
Review Trends in development and approval times for new therapeutics in the United States. [Nat Rev Drug Discov. 2003]
Review Trends in development and approval times for new therapeutics in the United States.
Reichert JM. Nat Rev Drug Discov. 2003 Sep; 2(9):695-702.
The state of innovation in drug development. [Clin Pharmacol Ther. 2008]
The state of innovation in drug development.
Kola I. Clin Pharmacol Ther. 2008 Feb; 83(2):227-30.
Quantitative image analysis: software systems in drug development trials. [Drug Discov Today. 2003]
Quantitative image analysis: software systems in drug development trials.
Eckstein F, Englmeier KH. Drug Discov Today. 2003 Oct 15; 8(20):922-3.
Lessons from 60 years of pharmaceutical innovation. [Nat Rev Drug Discov. 2009]
Lessons from 60 years of pharmaceutical innovation.
Munos B. Nat Rev Drug Discov. 2009 Dec; 8(12):959-68.

See reviews... See all...

Cited by 7 PubMed Central articles

Open Data, Open Source and Open Standards in chemistry: The Blue Obelisk five years on. [J Cheminform. 2011]
Open Data, Open Source and Open Standards in chemistry: The Blue Obelisk five years on.
O'Boyle NM, Guha R, Willighagen EL, Adams SE, Alvarsson J, Bradley JC, Filippov IV, Hanson RM, Hanwell MD, Hutchison GR, et al. J Cheminform. 2011 Oct 14; 3(1):37. Epub 2011 Oct 14.
Common characteristics of open source software development and applicability for drug discovery: a systematic review. [Health Res Policy Syst. 2011]
Common characteristics of open source software development and applicability for drug discovery: a systematic review.
Ardal C, Alstadsæter A, Røttingen JA. Health Res Policy Syst. 2011 Sep 28; 9:36. Epub 2011 Sep 28.
Chemical genetics of Plasmodium falciparum. [Nature. 2010]
Chemical genetics of Plasmodium falciparum.
Guiguemde WA, Shelat AA, Bouck D, Duffy S, Crowther GJ, Davis PH, Smithson DC, Connelly M, Clark J, Zhu F, et al. Nature. 2010 May 20; 465(7296):311-5.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Can open-source R&D reinvigorate drug research?
Can open-source R&D reinvigorate drug research?
Nat Rev Drug Discov. 2006 Sep ;5(9):723-9. Epub 2006 Aug 18 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: